Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
The regulatory approval arrived on the back of a clinical trial which found that participants lost an average of 14 per cent of their body weight over 64 weeks
At 72 weeks, tirzepatide produced an average weight reduction of about 20%, compared to roughly 14% with semaglutide
Over several months, weight loss becomes more noticeable
It works as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, helping to regulate blood sugar levels and promote weight loss
Preventive strategies focus primarily on maintaining adequate hydration and addressing modifiable risk factors
US$ 27.17
US$ 26.00
US$ 29.50
US$ 26.74
US$ 23.39
US$ 24.24
US$ 28.45
